Disclosures for "Real‑world Utility and Usability of the Multiple Sclerosis Disease Activity (MSDA) Blood Test: The Provider Experience"
-
Ms. Leyden has received personal compensation for serving as an employee of Octave.
-
Dr. Datta has received personal compensation for serving as an employee of Octave Bioscience. Dr. Datta has received personal compensation for serving as an employee of Kytopen. Dr. Datta has received personal compensation for serving as an employee of Artisan Bio. Dr. Datta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Octave Bioscience. Dr. Datta has a non-compensated relationship as a Scientific Advisory Board Member with Sophie's Neighborhood that is relevant to AAN interests or activities.
-
Ms. Chester has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Ms. Chester has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Ms. Chester has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Ms. Chester has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SanofiGenzyme. Ms. Chester has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono.
-
Author has nothing to disclose